XML 102 R93.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Information (Tabulation of Business Segment Information Based on Current Segmentation) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Jun. 30, 2021
Segment Reporting Information [Line Items]          
Total Consolidated Revenue $ 371,198 $ 234,396 $ 660,268 $ 453,222  
Total consolidated operating income excluding special items 70,234 41,309 106,671 83,612  
Restructuring expense (3,387) (1,166) (6,481) (4,082)  
Business acquisition and integration expense (9,060) (11,079) (35,613) (24,515)  
Total consolidated operating (loss) income 24,734 29,064 2,671 55,015  
Net other expense (25,068) (1,512) (71,583) (3,682)  
Total consolidated (loss) income from continuing operations before income taxes (334) 27,552 (68,912) 51,333  
Total Consolidated Assets 3,659,773 2,274,880 3,659,773 2,274,880 $ 3,084,843
Total Consolidated capital expenditures 8,081 7,388 14,772 19,704  
Total consolidated depreciation expense 11,631 8,512 22,130 16,722  
Total consolidated intangible asset amortization expense 30,699 0 47,150 0  
Discontinued Operations, Held-for-sale [Member]          
Segment Reporting Information [Line Items]          
Total Consolidated Assets 603,725 591,146 603,725 591,146  
Chamberlain University Segment [Member]          
Segment Reporting Information [Line Items]          
Total Consolidated Revenue 139,121 141,977 274,760 275,741  
Total consolidated operating income excluding special items 25,791 32,482 46,646 62,651  
Total Consolidated Assets 198,714 207,810 198,714 207,810  
Total Consolidated capital expenditures 2,969 4,843 6,614 12,594  
Total consolidated depreciation expense 4,726 4,067 9,310 7,907  
Walden University          
Segment Reporting Information [Line Items]          
Total Consolidated Revenue 140,627 0 209,244 0  
Total consolidated operating income excluding special items 32,401 0 43,413 0  
Total Consolidated Assets 1,540,977 0 1,540,977 0  
Total Consolidated capital expenditures 2,748 0 2,932 0  
Total consolidated depreciation expense 2,516 0 4,228 0  
Total consolidated intangible asset amortization expense 30,699 0 47,150 0  
Medical and Veterinary [Member]          
Segment Reporting Information [Line Items]          
Total Consolidated Revenue 91,450 92,419 176,264 177,481  
Total consolidated operating income excluding special items 19,706 18,808 35,371 41,649  
Restructuring expense (188)   (188)    
Total Consolidated Assets 722,055 779,466 722,055 779,466  
Total Consolidated capital expenditures 504 780 1,759 2,295  
Total consolidated depreciation expense 3,645 3,623 7,100 7,156  
Home Office and Other          
Segment Reporting Information [Line Items]          
Total consolidated operating income excluding special items (7,664) (9,981) (18,759) (20,688)  
Restructuring expense (1,073) (1,166) (4,167) (4,082)  
Total Consolidated Assets 594,302 696,458 594,302 696,458  
Total Consolidated capital expenditures 1,860 1,765 3,467 4,815  
Total consolidated depreciation expense 744 822 1,492 1,659  
Segment Reconciling Items [Member]          
Segment Reporting Information [Line Items]          
Deferred revenue adjustment (2,354) 0 (8,561) 0  
CEO transition costs 0 0 (6,195) 0  
Restructuring expense (3,387) (1,166) (6,481) (4,082)  
Business acquisition and integration expense (9,060) (11,079) (35,613) (24,515)  
Total consolidated intangible asset amortization expense $ 30,699 $ 0 $ 47,150 $ 0